Frenkel Rutenberg Tal, Vintenberg Maria, Khamudis Alexander, Rubin Tomer, Rutenberg Ran, Bdeir Abdelazeez, Shemesh Shai
Orthopedic Department, Rabin Medical Center, Beilinson Hospital, affiliated to the Sackler Faculty of Medicine, Aviv University, Tel Aviv, Israel.
Orthopedic Department, Rabin Medical Center, Beilinson Hospital, affiliated to the Sackler Faculty of Medicine, Aviv University, Tel Aviv, Israel.
Arch Gerontol Geriatr. 2021 Mar-Apr;93:104297. doi: 10.1016/j.archger.2020.104297. Epub 2020 Nov 18.
Diabetes mellitus (DM) and osteoporosis are both diseases of epidemic proportions with an increasing incidence worldwide. Fragility hip fractures (FHF) are associated with elevated morbidity, mortality, social burden and medical costs. The aim of this study was to determine whether patients with DM have worse medical and surgical outcomes following FHFs and whether the Diabetes Complications Severity Index (DCSI) can predict in-hospital complications and one-year mortality.
A single centre retrospective cohort study including 1343 patients older than 65 years who underwent surgery for FHFs was conducted. The data collected included length of hospital stay, time-to-surgery, blood loss, complications and mortality during the first post-operative year.
408 patients with a DM diagnosis were compared with 935 without DM. Pre-operatively, patients with DM had lower haemoglobin levels, higher platelet counts and worse renal function. Following surgery, patients with DM were more likely to be transferred to another department or intensive care. One-year mortality was significantly higher in the DM group [23.3% vs. 17.1%, odds ratio 1.36 (CI 1.029-1.799, p = 0.03)]. Higher DCSI scores were related with elevated one-year mortality rates in the DM group. Cerebrovascular events were found to be nearly five times more prevalent in the DM group. Patients with DM were more likely to continue treatment in a rehabilitation centre and had a higher probability to be re-hospitalized in the first post-operative year (p.<0.001).
Our results emphasize the increased vulnerability of this patient population and the importance of specialized care during the peri-operative period of FHFs.
糖尿病(DM)和骨质疏松症都是发病率呈全球上升趋势的流行病。脆性髋部骨折(FHF)与发病率、死亡率、社会负担和医疗成本升高相关。本研究的目的是确定糖尿病患者在发生脆性髋部骨折后是否有更差的医疗和手术结局,以及糖尿病并发症严重程度指数(DCSI)能否预测住院并发症和一年死亡率。
开展一项单中心回顾性队列研究,纳入1343例65岁以上接受脆性髋部骨折手术的患者。收集的数据包括住院时间、手术时间、失血量、术后第一年的并发症和死亡率。
将408例诊断为糖尿病的患者与935例非糖尿病患者进行比较。术前,糖尿病患者血红蛋白水平较低、血小板计数较高且肾功能较差。术后,糖尿病患者更有可能被转至其他科室或重症监护室。糖尿病组的一年死亡率显著更高[23.3%对17.1%,优势比1.36(可信区间1.029 - 1.799,p = 0.03)]。较高的DCSI评分与糖尿病组较高的一年死亡率相关。发现脑血管事件在糖尿病组中的发生率几乎高出四倍。糖尿病患者更有可能在康复中心继续接受治疗,且在术后第一年再次住院的可能性更高(p<0.001)。
我们的结果强调了这一患者群体的脆弱性增加以及在脆性髋部骨折围手术期进行专科护理的重要性。